Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

First in vivo evaluations of synaptic density alterations in the brain

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Finnema S, Nabulsi N, Eid T, Detyniecki K, Lin S, Chen M, et al. Imaging synaptic density in the living human brain by positron emission tomography. Sci Transl Med. 2016;8:348ra396.

    Article  Google Scholar 

  2. 2.

    Radhakrishnan R, Skosnik P, Ranganathan M, Naganawa M, Toyonaga T, Finnema S, et al. In vivo evidence of lower synaptic vesicle density in schizophrenia. Mol Psychiatry. 2021. [Epub ahead of print].

  3. 3.

    D’Souza D, Radhakrishnan R, Naganawa M, Ganesh S, Nabulsi N, Najafzadeh S, et al. Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder. Mol Psychiatry. 2020. [Epub ahead of print].

  4. 4.

    Mecca A, Chen M, O’Dell R, Naganawa M, Toyonaga T, Godek T, et al. In vivo measurement of widespread synaptic loss in Alzheimer’s disease with SV2A PET. Alzheimers Dement. 2020;16:974–82.

    Article  Google Scholar 

  5. 5.

    Holmes S, Scheinos D, Finnema S, Naganawa M, Davis M, DellaGioia N, et al. Lower synaptic density is associated with depression severity and network alterations. Nat Commun. 2019;10:1529.

    Article  Google Scholar 

  6. 6.

    Li N, Liu R, Dwyer J, Banasr M, Lee B, Son H, et al. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry. 2011;69:754–61.

    CAS  Article  Google Scholar 

Download references


This work was funded by R01MH118728 (IE) and UL1 TR001863 (SEH).

Author information




The authors contributed equally to the writing and editing of this document.

Corresponding author

Correspondence to Irina Esterlis.

Ethics declarations

Competing interests

The authors have no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Esterlis, I., Holmes, S. First in vivo evaluations of synaptic density alterations in the brain. Neuropsychopharmacol. (2021).

Download citation


Quick links